Evidence map›Paper›PMID 39052692›Full record

ArticlePLoS neglected tropical diseases2024

Clinical characteristics of enteric fever and performance of TUBEX TF IgM test in Indonesian hospitals.

Syndi Nurmawati, Anggraini Alam, Hofiya Djauhari, Tuti P Merati, Pratiwi Sudarmono, Vivi Setiawaty, Dona Arlinda, Retna Indah Sugiyono, Mansyur Arief, Usman Hadi and 10 more

Abstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Syndi NurmawatiIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Anggraini AlamIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Hofiya DjauhariIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Tuti P MeratiIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Pratiwi SudarmonoIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Vivi SetiawatyIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Dona ArlindaIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Retna Indah SugiyonoIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Mansyur AriefIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Usman HadiIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Abu Tholib AmanIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Dewi LokidaIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
M Hussein GasemIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Emiliana TjitraIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
C Jason LiangIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Aaron NealIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Herman KosasihIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Muhammad KaryanaIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Chuen-Yen LauIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.
Bachti AlisjahbanaIndonesia Research Partnership on Infectious Diseases (INA-RESPOND), Central Jakarta, Indonesia.ORCID 0000-0003-3745-8229

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003I
6 · The paper itself

Abstract

backgroundAccurate diagnosis of enteric fever is challenging, particularly in low- and middle-income countries, due to the overlap of clinical and laboratory features with other pathogens. To better understand the difficulties in enteric fever diagnosis, we evaluated the characteristics of patients clinically diagnosed with enteric fever and the real-world performance of TUBEX TF, one of the most used tests in Indonesia. METHODOLOGY/PRINCIPAL

findingsPatients were recruited through the AFIRE (Etiology of Acute Febrile Illness Requiring Hospitalization) study at eight Indonesian hospitals. Blood culture was performed for all patients, and TUBEX TF was performed for suspected enteric cases. Salmonella PCR and ELISA tests were performed at a reference lab. Sensitivity and specificity of TUBEX TF and IgM and IgG anti-S. Typhi ELISA were determined. Of 301 patients clinically diagnosed with enteric fever, 50 (16.6%) were confirmed by blood culture and/or PCR. Confirmed cases were mostly school-aged children presenting with fever, anorexia, dizziness and/or abdominal pain with normal leukocyte count or leukopenia. TUBEX TF demonstrated a sensitivity of 97.6% to 70.7% and specificity of 38.3% to 67.2% at cutoffs of 4 and 6, respectively. Acute IgG demonstrated the best sensitivity and specificity, at 90.7% and 82.7%, respectively, and the best ROC characteristics. CONCLUSIONS/SIGNIFICANCE: A substantial proportion of enteric fever was misdiagnosed at all study hospitals, likely due to the overlap of clinical characteristics and lab parameters with those of other common pathogens. The TUBEX TF rapid serological assay demonstrated suboptimal performance in our setting and tended to over-diagnose enteric fever. The role of IgG from acute specimens for identification of enteric fever cases merits additional consideration.

Indexed as

Antibodies, BacterialEnzyme-Linked Immunosorbent AssayImmunoglobulin GImmunoglobulin MSensitivity and SpecificityTyphoid FeverAdolescentAdultAgedChildChild, PreschoolFemaleHospitalsHumansIndonesiaInfantAntibodies, BacterialImmunoglobulin GImmunoglobulin M

Identifiers

PMID39052692
PMCPMC11315288

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.